Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), often combined with systemic therapy, can be offered to selected colorectal peritoneal metastases (PM) patients. However, clinical heterogeneity and the lack of high-level evidence challenges determination of the corr...

Descripción completa

Detalles Bibliográficos
Autores principales: Simkens, Geert A, Wintjens, Anne G W E, Rovers, Koen P, Nienhuijs, Simon W, de Hingh, Ignace H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257566/
https://www.ncbi.nlm.nih.gov/pubmed/34234566
http://dx.doi.org/10.2147/CMAR.S277912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257566/
https://www.ncbi.nlm.nih.gov/pubmed/34234566
http://dx.doi.org/10.2147/CMAR.S277912

Ejemplares similares